TOP STORIES

• ORGANIZATION PhRMA Sounds Alarm on “Huge Seller” Re-Pricing, Possible Decline in Japan Investment
  December 14, 2015

• REGULATORY 6 Drug Makers to Participate in AMED’s Drug Discovery Consortium
  December 11, 2015

• REGULATORY 3 Trade Groups Vehemently Oppose “Huge Seller” Drug Re-Pricing, Say It Will Hobble Innovation
  December 10, 2015

• TRENDS “Huge Seller” Re-Pricing Targeting Hep C Drugs Will Dampen Innovative Market
  December 9, 2015

• REGULATORY LDP Budget Debate in Homestretch; Govt Eyes “Huge Sellers”, Generics, Z2 to Squeak Out Funds for Upping Physician Fees
  December 9, 2015

• REGULATORY PMDA to Begin Unannounced Regular Inspections in Wake of GMP Violations by Kaketsuken
  December 8, 2015

• TRENDS Peak Sales Forecast for New Drugs Listed in 2015 Exceeded 840 Billion Yen with Big Contribution from Hep C Treatments
  December 7, 2015

• BUSINESS Unusualness of Hep C Market Not Being Understood, Gilead COO Says on Possible Sovaldi Re-Pricing
  December 4, 2015

• REGULATORY Probe Finds Kaketsuken’s GMP Violations “Extremely Malicious”, MHLW to Impose Penalty
  December 3, 2015

• REGULATORY NHI-Market Price Gap at 8.8%, 6.8% Price Cut Expected in FY2016 Revision
  December 3, 2015

• REGULATORY MHLW Discussing Use of Disease Registry as Substitute for Control Groups; Could Be “One Means of Evaluation” in Trials for Rare Diseases
  December 2, 2015

• BUSINESS Mitsubishi Tanabe Set to Derive 40% of Sales Abroad in FY2020, Shed 1,200 Jobs over 5 Years
  December 1, 2015

• BUSINESS Takeda, Teva Hook Up to Form Generic Joint Venture in Japan
  November 30, 2015

• TRENDS AG Shares Reach 50-60% in 1 Year; Confidence in Quality Encourages Dominance Even without Market Lead
  November 30, 2015

• REGULATORY Evaluation of Efficacy Was Challenging in Sakigake Pick, Designating All Qualified Drugs Desirable: MHLW Official
  November 27, 2015

• REGULATORY Drug Pricing Debate to Culminate in December; Abraxane, Zosyn Major Candidates for Market Expansion Re-Pricing
  November 26, 2015

• REGULATORY Don’t Seek Near-Term Profits but Have Long-Term Vision, MHLW Official Tells Drug Makers
  November 25, 2015

• REGULATORY MHLW Eyes Using HTA to Re-Price Drugs with Big Sales Outlooks That Have Gone Through 1 or 2 Price Revisions
  November 24, 2015

• ACADEMIA Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?
  November 20, 2015

• ORGANIZATION Industry Wants OTC Tax Break and No Annual Price Cuts, Groups Tell LDP
  November 19, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• …
• Next ›
• 最終 »